Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology IV1 Apr 2017MP99-04 TRUNCATED-CRMP4 BY CALPAIN-2 SUPPRESSES CRMP4 TO PROMOTE METASTASIS OF PROSTATE CANCER VIA PROMOTER METHYLATION THROUGH E2F1/NF-?B/DNMT1 SIGNALING Xin Gao, Yunhua Mao, Zheng Chen, Jun Pang, and Ke Li Xin GaoXin Gao More articles by this author , Yunhua MaoYunhua Mao More articles by this author , Zheng ChenZheng Chen More articles by this author , Jun PangJun Pang More articles by this author , and Ke LiKe Li More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.3090AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Metastasis is the primary cause of cancer-specific death in patients with prostate cancer (PCa). Previous studies identified promoter methylation is responsible for the repression of the tumor metastasis-suppressor gene collapsing response mediator protein-4 (CRMP4) in metastatic PCa. However, the underlying mechanisms for promoter methylation remain unknown. METHODS In this study, calpain-2 expression in prostatic benign and cancer tissues was determined using immunohistochemistry (IHC). The effects of truncated-CRMP4 by calpain-2 in migration and invasion of PCa cells and the underlying mechanisms were explored. The role of nuclear factor-kappaB (NF-kB) in CRMP4 promoter methylation was evaluated. In addition, the downstream signaling regulated by CRMP4 were determined. RESULTS Calpain-2 was differentially upregulated in metastatic PCa Calpain-2 was differentially upregulated in metastatic PCa tissues. N-terminally truncated-CRMP4 by calpain-2 enhanced the ability of migration and invasion via nuclear translocation and subsequently activation of E2F1-mediated DNA methyltransferase 1 (DNMT1) expression. In addition, NF-kB RelA/p65 recruited DNMT1 to directly bind to and methylate the CRMP4 promoter in which Serine276 phosphorylation of p65 was essential. Furthermore, CRMP4 CRMP4 exhibited anti-metastatic function by inhibiting the expression of vascular endothelial growth factor C (VEGFC) via Sema3B- Neuropilin2 signaling. CONCLUSIONS Calpain-mediated cleavage of CRMP4 promotes PCa metastasis by suppression of CRMP4 transcription via nuclear translocation of N-terminally truncated fragment and subsequent activation of E2F1/NF-kB/DNMT1 signaling which in turn enhanced CRMP4 promoter hypermethylation. Targeting re-expression of CRMP4 may be of great significance in the treatment of patients with metastatic PCa. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e1321 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Xin Gao More articles by this author Yunhua Mao More articles by this author Zheng Chen More articles by this author Jun Pang More articles by this author Ke Li More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Calpain 2 up-regulate C499 in the prostatic stroma and promotes the proliferation of interstitial cells, leading to the occurrence of BPH

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia.

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate

M2 Macrophage-Mediated Interleukin-4 Signalling Induces Myofibroblast Phenotype During the Progression of Benign Prostatic Hyperplasia

Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates

Differences in Phenotype and Gene Expression of Prostate Stromal Cells from Patients of Varying Ages and Their Influence on Tumour Formation by Prostate Epithelial Cells

STEAP4 Modulates Cell Proliferation and Oxidative Stress in Benign Prostatic Hyperplasia.

Effect of Benign Prostatic Hyperplasia on the Deposit of Collagen on the Ageing Rat Bladder

Mitogen-Activated Protein Kinase Pathway and Four Genes Involved in the Development of Benign Prostatic Hyperplasia: <i>In Vivo</i> and <i>Vitro</i> Validation

Increased Infiltrated Macrophages in Benign Prostatic Hyperplasia (BPH): ROLE OF STROMAL ANDROGEN RECEPTOR IN MACROPHAGE-INDUCED PROSTATE STROMAL CELL PROLIFERATION

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia

Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.

Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate

Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic Hyperplasia.

Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway

Mp99-04 truncated-crmp4 by calpain-2 suppresses crmp4 to promote metastasis of prostate cancer via promoter methylation through e2f1/nf-?b/dnmt1 signaling

391 Upregulation of Phosphodiesterase Type 4 in the Hyperplastic Prostate

CCR2+ monocytes/macrophages drive steroid hormone imbalance-related prostatic fibrosis

Expression of Ki-67, Bcl-2, Bax and Caspase-3 in Benign Prostatic Hyperplasia Combined with Prostatitis and Their Significances

Elevated Anaphylatoxin C3a in Expressed Prostatic Secretion Correlates with Prostatic Inflammation Extent in Benign Prostatic Hyperplasia